Sarah is a clinical research coordinator and integration coach specializing in psychopharmacology and neuropsychology. With a strong academic foundation and hands-on experience in psychedelic-assisted therapies, she is dedicated to supporting individuals through their ketamine treatment journeys.
Sarah holds a Master of Science in Psychology with a specialization in Neuropsychology from Maastricht University in the Netherlands. Her research focused on the intersection of mood and pain tolerance in psychopharmacological treatments.
She also earned a Bachelor of Science in Psychology from the University of Utah, where she explored the therapeutic potential of ketamine-assisted psychotherapy for older adults with early cognitive decline. In addition, she has received specialized training in psychedelic therapy through the Salt City Psychedelic Therapy and Research (SCPTR) program. Sarah has led clinical research on emerging psychedelic treatments, including the first-ever Phase 1 study.